Publications of E. B. Binder
All genres
Journal Article (426)
341.
Journal Article
42 (5), p. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 342.
Journal Article
42 (5), p. 223 - 223 (2009)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 343.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 344.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 345.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 346.
Journal Article
42 (5), p. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 347.
Journal Article
32 (3), pp. 549 - 575 (2009)
The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology. Psychiatric Clinics of North America 348.
Journal Article
42 (5), p. 230 - 230 (2009)
Genome-wide association study of antidepressant induced treatment emergent suicidal ideation (TESI). Pharmacopsychiatry 349.
Journal Article
42 (5), p. 244 - 244 (2009)
Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients. Pharmacopsychiatry 350.
Journal Article
42 (5), p. 246 - 246 (2009)
Polymorphisms within the 4-aminobutyrate aminotransferase gene are associated with long-latency somatosensory potentials in families vulnerable for affective disorders. Pharmacopsychiatry 351.
Journal Article
42 (5), p. 249 - 249 (2009)
The interplay of variations in the FKBP5 gene and adverse life events in predicting the first onset of depression during a ten-year follow-up. Pharmacopsychiatry 352.
Journal Article
116 (6), pp. 649 - 657 (2009)
The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 353.
Journal Article
65 (8 Suppl. S), p. 230S - 230S (2009)
Association of the Adrenergic Receptor Alpha l B with Antidepressant Treatment in the MARS Study. Biological Psychiatry 354.
Journal Article
65 (8 Suppl. S), pp. 230S - 231S (2009)
Subset of Genetic Markers Associated with Antidepressant Treatment Emergent Suicidal Ideation. Biological Psychiatry 355.
Journal Article
19 (Suppl. 1), pp. S68 - S69 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients. European Neuropsychopharmacology 356.
Journal Article
34 (1), pp. 99 - 109 (2009)
HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 357.
Journal Article
43 (3), pp. 215 - 229 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 358.
Journal Article
13 (Suppl. 1), pp. 31 - 32 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich antidepressant response signature project. International Journal of Psychiatry in Clinical Practice 359.
Journal Article
147B (7), pp. 1196 - 1204 (2008)
Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 360.
Journal Article
18 (Suppl. 4), pp. S214 - S215 (2008)
Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients. European Neuropsychopharmacology